Seer, Inc.

Contributing Author

Recent Articles by Seer, Inc.

Jun-03	Seer Files Definitive Proxy Materials and Mails Letter to Stockholders SEER GlobeNewswire
May-29	Seer Files ITC Complaint Against Nanomics SEER GlobeNewswire
May-26	Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026 SEER GlobeNewswire
May-21	Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group SEER +5.36% GlobeNewswire
May-13	Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook SEER GlobeNewswire
May-13	Seer Files Patent Infringement Lawsuit Against Nanomics SEER GlobeNewswire
May-04	Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer SEER GlobeNewswire
Apr-29	Seer to Report First Quarter 2026 Financial Results on May 13, 2026 SEER GlobeNewswire
Apr-27	Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group SEER GlobeNewswire
Apr-13	Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group SEER +13.61% GlobeNewswire
Apr-09	Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples SEER GlobeNewswire
Mar-30	Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries SEER GlobeNewswire
Feb-26	Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets SEER -17.31% SEER GlobeNewswire
Feb-26	Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook SEER -17.31% SEER GlobeNewswire
Feb-19	Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026 SEER GlobeNewswire
Feb-18	Seer to Participate in the TD Cowen 46th Annual Health Care Conference SEER GlobeNewswire
Feb-05	Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 SEER GlobeNewswire
Dec-01	Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers SEER GlobeNewswire
Nov-07	Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 SEER GlobeNewswire
Nov-06	Seer Reports Third Quarter 2025 Financial Results SEER GlobeNewswire
Oct-29	Seer to Participate in Upcoming November Investor Conferences SEER GlobeNewswire
Oct-16	Seer to Report Third Quarter 2025 Financial Results on November 6, 2025 SEER GlobeNewswire
Oct-10	Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025 SEER GlobeNewswire
Sep-02	Seer Appoints Isaac Ro to its Board of Directors SEER GlobeNewswire
Aug-26	Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference SEER GlobeNewswire
Aug-06	Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook SEER GlobeNewswire
Jul-31	Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference SEER GlobeNewswire
Jul-22	Seer to Report Second Quarter 2025 Financial Results on August 6, 2025 SEER GlobeNewswire
Jun-01	Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults SEER GlobeNewswire
May-29	Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency SEER GlobeNewswire
May-13	Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook SEER +9.90% SEER GlobeNewswire

Seer, Inc.

Recent Articles by Seer, Inc.

Upgrade your Finviz experience